Beijing Konruns Pharmaceutical Co.,Ltd.’s Net Profit Rose 15.1% in First Half of 2023

Beijing Konruns Pharmaceutical Co.,Ltd. (北京康辰药业股份有限公司) (603590.SH) reported a net profit of 103.4 million yuan in the first half of 2023, up 15.1% year-on-year.

Meanwhile, the company posted 450.8 million yuan in revenue, up 21.3% year-on-year.

At the end of the reporting period, it had 3.7 billion yuan in total assets and 359.2 million yuan in total liabilities, with a liability-to-asset ratio of 9.7%.